Pfizer and Cellectis enter into global strategic cancer immunotherapy collaboration
Pfizer Inc. (NYSE:PFE) and Cellectis (Paris:ALCLS) have entered into a global strategic...
Read moreDeath by prescription painkiller
The number of deaths involving commonly prescribed painkillers is higher than the number of deaths...
Read morePfizer opens new state-of-the-Art research and development site in Cambridge, Massachusetts
Pfizer Inc. (NYSE:PFE) has announced the opening of a new 280,000 square-foot Research and...
Read moreEMA lifts drug export ban on Ranbaxy's Toansa manufacturing plant
The European Medicines Agency (EMA) has lifted suspension imposed on export of drugs produced at...
Read moreAustralian animal health firm chooses KC for U.S. headquarters
Jurox Pty. Ltd., an Australian veterinary pharmaceutical company, has selected Kansas City as the...
Read morePharma's Out-With-the-Old Deals Could Struggle
Cosmetic surgery might make you look better but it can't stop the aging process. Some big...
Read more'We Want to Establish Hospitals, Pharmaceutical Industry'
The Pakistan government has expressed its readiness to partner with Nigeria to establish hospitals...
Read moreShasun Pharma bets big on formulations in regulated markets
Looking at setting up a manufacturing facility for formulations, expansion in API capacity.
Read moreNigeria, emerging hub for pharma market expansion in Africa
As growth opportunities continue to move away from traditional pharmaceutical markets and growth...
Read moreA war on (pharmaceutical) drugs
The insurance industry is picking a fight with companies over the rising cost of specialty drugs.
Read more



